Evidence map›Paper›PMID 24386231›Full record

ArticlePloS one2013

mRNA transfection of mouse and human neural stem cell cultures.

Samuel McLenachan, Dan Zhang, Ana Belén Alvarez Palomo, Michael J Edel, Fred K Chen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection.International journal of molecular sciences · 2020
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Efficient Generation of Dopamine Neurons by Synthetic Transcription Factor mRNAs.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  14. Biomaterials for mRNA delivery.Biomaterials science · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Samuel McLenachanCentre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia ; Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia.
Dan ZhangCentre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia ; Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia.
Ana Belén Alvarez PalomoControl of Pluripotency Laboratory, Molecular Genetics Research Group, Department of Physiological Sciences I, University of Barcelona, Barcelona, Spain.
Michael J EdelControl of Pluripotency Laboratory, Molecular Genetics Research Group, Department of Physiological Sciences I, University of Barcelona, Barcelona, Spain ; University of Sydney Medical School, Faculty of Medicine, Westmead Childrens Hospital, Division of Pediatrics and Child Health, Sydney, Australia.
Fred K ChenCentre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia ; Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia ; Ophthalmology Department, Royal Perth Hospital, Wellington Street, Perth, Western Australia, Australia.
Lions Eye Institute · AUUniversitat de Barcelona · ESUniversity of Sydney · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs provides an effective method for inducing transient gene expression in cell cultures without genetic modification. Delivery of mRNA has been proposed as a safer alternative to viral vectors in the induction of pluripotent cells for regenerative therapies. Although mRNA transfection of fibroblasts, dendritic and embryonic stem cells has been described, mRNA delivery to neurosphere cultures has not been previously reported. Here we sought to establish an efficient method for delivering mRNA to primary neurosphere cultures. Neurospheres derived from the subventricular zone of adult mice or from human embryonic stem cells were transfected with EGFP mRNA by lipofection and electroporation. Transfection efficiency and expression levels were monitored by flow cytometry. Cell survival following transfection was examined using live cell counting and the MTT assay. Both lipofection and electroporation provided high efficiency transfection of neurospheres. In comparison with lipofection, electroporation resulted in increased transfection efficiencies, but lower expression per cell and shorter durations of expression. Additional rounds of lipofection renewed EGFP expression in neurospheres, suggesting this method may be suitable for reprogramming applications. In summary, we have developed a protocol for achieving high efficiency transfection rates in mouse and human neurosphere cell culture that can be applied for future studies of gene function studies in neural stem cells, such as defining efficient differentiation protocols for glial and neuronal linages.

Indexed as

TransfectionAnimalsCell Culture TechniquesCyclin D1Flow CytometryGene ExpressionGenes, ReporterHumansMiceNeural Stem CellsRNA, MessengerSpheroids, CellularCyclin D1RNA, Messenger

Identifiers

PMID24386231
PMCPMC3873397
OpenAlexW2029708918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.